- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:54 | Bitfarms FY 2025 slides: $229M revenue amid $209M loss, AI pivot | ||
| 15:54 | AirJoule Q4 2025 slides: first revenue amid $9M loss, cash through 2027 | ||
| 15:54 | Beretta Holding criticizes Sturm, Ruger board over tender offer rejection | ||
| 15:54 | Rain Enhancement reports snowpack gains at Utah site during drought | ||
| 15:54 | IBM, ETH Zurich partner on 10-year algorithm research initiative | ||
| 15:54 | DA Davidson lowers Winnebago stock price target on macro concerns | ||
| 15:54 | DA Davidson cuts Phreesia stock price target on lowered revenue guide | ||
| 15:54 | Fulcrum stock seen undervalued as Stifel cites FDA flexibility | ||
| 15:54 | Hirequest stock maintained at Buy by DA Davidson after Q4 results | ||
| 15:42 | Truist reiterates Agios Pharma stock rating on accelerated approval path | ||
| 15:42 | Jefferies lowers Ormat Technologies stock price target on muted outlook | ||
| 15:42 | Jefferies lowers Array Technologies stock price target on margin concerns | ||
| 15:18 | J.Jill March 2026 slides: margins compress as growth initiatives take shape | ||
| 15:18 | AIRO Q4 2025 slides: revenue growth masks margin compression concerns | ||
| 15:18 | Ernexa plans ovarian cancer trial for cell therapy ERNA-101 | ||
| 15:18 | Kartoon Studios reports 21% revenue growth for 2025 | ||
| 15:18 | Diginex to consolidate four units into single ESG platform | ||
| 15:18 | Enveric Biosciences receives U.S. patent for EVM301 molecules | ||
| 15:18 | IMUNON reports final Phase 2 data for ovarian cancer treatment | ||
| 15:18 | CrowdStrike, HCLTech launch threat exposure management services | ||
| 15:18 | Photronics installs advanced mask writer at Korea facility | ||
| 15:18 | CoreWeave closes $8.5B credit facility for AI cloud expansion | ||
| 15:18 | Jefferies raises NextEra Energy stock price target on growth outlook | ||
| 15:18 | Barclays reiterates McCormick stock rating at Equalweight, $58 target | ||
| 15:18 | FactSet shares hold at Stifel as Q2 results beat expectations |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.